申请人:Schering Aktiengesellschaft
公开号:US03960949A1
公开(公告)日:1976-06-01
1,2-Substituted biguanides of the formula ##EQU1## wherein R.sub.1 is saturated or unsaturated, straight-chain or branched hydrocarbon of 1-12 carbon atoms which is unsubstituted or substituted by one or more fluorine atoms; a cycloalkyl group of 3-6 carbon atoms; or an aryl or aralkyl group of the formula ##SPC1## With n being the integer 0, 1 or 2 and X being hydrogen or halogen; and R'.sub.1 is a hydrogen atom or a saturated or unsaturated, straight-chain or branched hydrocarbon group of 1-12 carbon atoms; or R.sub.1 and R'.sub.1 collectively with the nitrogen atom to which they are attached are a heterocyclic ring containing one or more hetero atoms; and R.sub.2 is saturated or unsaturated, straight-chain or branched hydrocarbon of 1-12 carbon atoms which is unsubstituted or substituted by one or more fluorine atoms; or cycloalkyl of 3-6 carbon atoms, alkoxyalkyl containing a total of 2-12 carbon atoms, or alkoxy of 1-6 atoms; mixtures thereof, and pharmaceutically acceptable acid addition salts thereof, are useful in the treatment of diabetes mellitus.
1,2-取代的双胍衍生物,其公式为##EQU1##,其中R.sub.1是饱和或不饱和的、直链或支链的1-12碳原子的烃,可以是未取代的或由一个或多个氟原子取代的;一个3-6碳原子的环烷基团;或者是一个公式的芳基或芳烷基团##SPC1##,其中n是整数0、1或2,X是氢或卤素;R'.sub.1是一个氢原子或一个饱和或不饱和的、直链或支链的1-12碳原子的烃基团;或者R.sub.1和R'.sub.1与它们连接的氮原子共同构成一个含有一个或多个杂原子的杂环;R.sub.2是饱和或不饱和的、直链或支链的1-12碳原子的烃,可以是未取代的或由一个或多个氟原子取代的;或者是一个3-6碳原子的环烷基,含有总共2-12碳原子的烷氧基烷基,或1-6原子的烷氧基;其混合物,以及它们的药物可接受的酸加成盐,在治疗糖尿病方面是有用的。